A0A2J8RXL6 (A0A2J8RXL6_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)
cAMP-dependent protein kinase catalytic subunit alpha UniProtKBInterProInteractive Modelling
351 aa; Sequence (Fasta) ;
10 identical sequences: Homo sapiens: P17612; Pan troglodytes: K7AVQ3, K7ANZ9; Gorilla gorilla gorilla: A0A2I2YB49; Theropithecus gelada: A0A8D2EME3; Papio anubis: A0A2I3NH23; Macaca nemestrina: A0A2K6DZQ7; Macaca mulatta: H9EQQ4; Macaca fascicularis: A0A2K5UC31; Rhinopithecus roxellana: A0A2K6P4Q4
Available Structures
48 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Protein kinase A sixfold mutant model of Aurora B with inhibitor JNJ-7706621 |
Heteromer P17612; P61925; | 1×SKE; | ||||
| Assess | ||||||
| Protein kinase A sixfold mutant model of Aurora B with inhibitor VX-680 |
Heteromer P17612; P61925; | 1×VX6; | ||||
| Assess | ||||||
| Protein Kinase A in complex with an Inhibitor |
Heteromer P17612; P61925; | 1×8BQ; 2×MPD; | ||||
| Assess | ||||||
| Bromine SAD partially resolves multiple binding modes for PKA inhibitor H-89 |
Heteromer P17612; P61925; | 1×IQB; 1×MPD; | ||||
| Assess | ||||||
| PKA in complex with a halogenated phthalazinone fragment compound. |
Heteromer P17612; P61925; | 1×495; 3×MPD; | ||||
| Assess | ||||||
| PKA in complex with a benzothiophene fragment compound. |
Heteromer P17612; P61925; | 1×4W1; 2×MPD; 1×EDO; | ||||
| Assess | ||||||
| Protein kinase A mutants as surrogate model for Aurora B with AT9283 inhibitor |
Heteromer P17612; P61925; | 1×35R; | ||||
| Assess | ||||||
| Protein Kinase A in complex with an Inhibitor |
Heteromer P17612; P61925; | 1×S3N; 2×MPD; | ||||
| Assess | ||||||
| Crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 18 |
Heteromer P17612; P61925; | 1×L9M; | ||||
| Assess | ||||||
| Crystal structure of pka with compound 36 |
Heteromer P17612; P61925; | 1×L9L; | ||||
| Assess | ||||||
| Crystal Structure of the full-length wild-type PKA RIa Holoenzyme |
Heteromer P00514; P17612; | |||||
| Assess | ||||||
| PKA variant as Aurora B mimic in complex with a dianilinopyrimidine inhibitor |
Heteromer P17612; P61925; | 1×E3Z; | ||||
| Assess | ||||||
| Crystal structure of human cAMP-dependent protein kinase A (catalytic alpha subunit) |
Heteromer P17612; P61925; | 1×ATP; 2×MG; | ||||
| Assess | ||||||
| Difluorophenyl diacylhydrazides: Potent inhibitors of Serum- and Glucocorticoid-inducible Kinase 1 … |
Heteromer P17612; P61925; | 1×J4B; | ||||
| Assess | ||||||
| Protein Kinase A in complex with an Inhibitor |
Heteromer P17612; P61925; | 1×4L7; 1×BR; 1×MPD; | ||||
| Assess | ||||||
| Crystal structure of a L205R mutant of human cAMP-dependent protein kinase A (catalytic alpha subun… |
Heteromer P17612; P61925; | 1×ATP; 2×MG; | ||||
| Assess | ||||||
| Structures of the PKA RI alpha holoenzyme with the FLHCC driver J-PKAc alpha or native PRKAc alpha |
Heteromer P00514; P17612; | |||||
| Assess | ||||||
| Human cAMP-dependent protein kinase in complex with an inhibitor |
Heteromer P17612; P61925; | 1×1SB; 1×BUD; | ||||
| Assess | ||||||
| human cAMP-dependent protein kinase in complex with an inhibitor |
Heteromer P17612; P61925; | 1×S69; 1×BUD; | ||||
| Assess | ||||||
| Protein Kinase A in complex with an Inhibitor |
Heteromer P17612; P61925; | 1×NVX; 1×MPD; | ||||
| Assess | ||||||
| crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 27 |
Heteromer P17612; P61925; | 1×L9N; | ||||
| Assess | ||||||
| Protein Kinase A in complex with an Inhibitor |
Heteromer P17612; P61925; | 1×NVV; 1×MPD; | ||||
| Assess | ||||||
| Human cAMP-dependent protein kinase in complex with an inhibitor |
Heteromer P17612; P61925; | 1×4SB; | ||||
| Assess | ||||||
| Human cAMP-dependent protein kinase in complex with an inhibitor |
Heteromer P17612; P61925; | 1×3SB; | ||||
| Assess | ||||||
| Discovery of 2-Pyrimidyl-5-Amidothiophenes as Novel and Potent Inhibitors for AKT: Synthesis and SA… |
Heteromer P17612; | 1×796; | ||||
| Assess | ||||||
| Crystal Structure of PKA bound to an pyrrolo pyridine inhibitor |
Heteromer P17612; P61926; | 1×504; | ||||
| Assess | ||||||
| Crystal structure of human cAMP-dependent protein kinase A (catalytic alpha subunit), exon 1 deleti… |
Heteromer P17612; P61925; | 1×ATP; 2×MG; 1×MES; | ||||
| Assess | ||||||
| Human cAMP-dependent protein kinase in complex with an inhibitor |
Heteromer P17612; P61925; | 1×2SB; | ||||
| Assess | ||||||
| Crystal structure of a chimeric fusion of human DnaJ (Hsp40) and cAMP-dependent protein kinase A (c… |
Heteromer P17612; P25685; P61925; | 1×ATP; 9×ZN; | ||||
| Assess | ||||||
| human cAMP dependent protein kinase in complex with phenol |
Heteromer P17612; P61925; | 3×IPH; | ||||
| Assess | ||||||
| Structure of J-PKAc chimera complexed with Aplithianine A |
Heteromer P17612; P25685; P61925; | 1×XTI; | ||||
| Assess | ||||||
| Human cyclic AMP-dependent protein kinase PKA inhibitor complex |
Heteromer P17612; P61925; | 1×XFE; | ||||
| Assess | ||||||
| Structure of J-PKAc chimera complexed with Aplithianine B |
Heteromer P17612; P25685; P61925; | 1×XTT; | ||||
| Assess | ||||||
| Structure of J-PKAc chimera complexed with Aplithianine derivative |
Heteromer P17612; P25685; P61925; | 1×XU0; | ||||
| Assess | ||||||
| Structures of the PKA RI alpha holoenzyme with the FLHCC driver J-PKAc alpha or native PKAc alpha |
Heteromer P00514; P17612; P25685; | 2×ATP; 4×MG; | ||||
| Assess | ||||||
| PKA RIIbeta holoenzyme with DnaJB1-PKAc fusion in fibrolamellar hepatoceullar carcinoma |
Heteromer P12369; P17612; P25685; | |||||
| Assess | ||||||
| human cAMP-dependent protein kinase in complex with a small fragment |
Heteromer P17612; P61925; | 1×YTP; | ||||
| Assess | ||||||
| PKA RIIbeta holoenzyme with DnaJB1-PKAc fusion in fibrolamellar hepatoceullar carcinoma |
Heteromer P12369; P17612; | |||||
| Assess | ||||||
| Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1416 | monomer | 3×SO4; 1×6J9; | ||||
| Assess | ||||||
| Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1039 | monomer | 1×A03; | ||||
| Assess | ||||||
| Crystal structure of cAMP-dependent protein kinase Calpha subunit bound with N46 | monomer | 1×EE4; 3×DMS; 1×PO4; | ||||
| Assess | ||||||
| Complex of PKA with the bisubstrate protein kinase inhibitor ARC-670 | monomer | |||||
| Assess | ||||||
| Structure and Function of the Human Sperm-Specific Isoform of Protein Kinase A (PKA) Catalytic Subu… | monomer | |||||
| Assess | ||||||
| Structure and function of the Human Sperm-Specific Isoform of Protein Kinase A (PKA) Catalytic Subu… | monomer | |||||
| Assess | ||||||
| Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1408 | monomer | 4×SO4; | ||||
| Assess | ||||||
| Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411 | monomer | 13×PO4; 1×6J9; | ||||
| Assess | ||||||
| Crystal structure of human PRKACA complexed with DS01080522 | monomer | 1×I5G; | ||||
| Assess | ||||||
| The Crystal Structure of PRKACA from Biortus. | monomer | 1×RKD; 1×NA; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3ovv.1.A | monomer | 0.90 | 1×1SB; | 100.00 | ||
| Assess | ||||||
| 3k3i.1.A | monomer | 0.62 | 25.27 | |||
| Assess | ||||||